Clicky

Lexaria Bioscience Corp.(LEXX)

Description: Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.


Keywords: Pharmacy Health Sciences Psychoactive Drugs Nutraceutical Drug Delivery Smoking Nicotine Natural Product Anxiolytics Alkaloids Found In Erythroxylum Coca

Home Page: www.lexariabioscience.com

LEXX Technical Analysis

#100 – 740 McCurdy Road
Kelowna, BC V1X 2P7
Canada
Phone: 250-765-6424


Officers

Name Title
Mr. Christopher A. Bunka Chairman & CEO
Mr. John M. Docherty M.Sc. Pres & Director
Mr. Gregory John Downey CMA, CPA CFO & Treasurer
Vanessa Carle Head of Legal
Dr. Philip N. Ainslie Ph.D. Advisor & Consultant

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.1936
Price-to-Sales TTM: 65.0074
IPO Date: 2006-10-10
Fiscal Year End: August
Full Time Employees: 7
Back to stocks